Niki BioSolutions, Inc. (NIKI)
Last updated: 2026-10-20 20:30:01. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Niki BioSolutions, Inc. (NIKI) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $2.02, with a market capitalization of $1.65M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.91 to $12.24. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.65M | |
$2.07 | |
$12.24 | |
$1.91 | |
$2.08 | |
21.61K | |
146.48K | |
-- | |
$12.24 | |
$1.91 | |
-- | |
-- |
Niki BioSolutions, Inc. (NIKI) After-Hours Stock Price
Niki BioSolutions, Inc. (NIKI) is trading at $1.97 in after-hours trading as of 2026-10-20 20:20:00, down 5.29% ($0.11) from the regular-session close of $2.08.
After-hours trading shows how investors are pricing NIKI after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Niki BioSolutions, Inc. (NIKI) 7-Day Stock Price Change
Over the past seven days, Niki BioSolutions, Inc. (NIKI) moved from $4.00 to $2.02, representing a decline of 49.53% ($1.98).
The stock traded between $1.91 and $4.38 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 22.62 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
NIKI 52-Week Price Position
Position in Range: 1.1%
NIKI is currently trading at $2.02, placing it 1.1% of the way from its 52-week low of $1.91 to its 52-week high of $12.24. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Niki BioSolutions, Inc. (NIKI)?
Niki BioSolutions Inc, formerly Aptorum Group Ltd is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its project pipeline includes SACT-1, a repurposed drug for the treatment of neuroblastoma, and ALS-4, a small molecule for the treatment of bacterial infections caused by Staphylococcus aureus, including but not limited to Methicillin-resistant Staphylococcus aureus (MRSA).
Niki BioSolutions, Inc. Information
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Niki BioSolutions, Inc. (NIKI) Stock on MEXC
Eligible investors can buy real shares of Niki BioSolutions, Inc. (NIKI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Niki BioSolutions, Inc. (NIKI) stock price today?
2.Is NIKI stock going up or down today?
3.What is NIKI pre-market price?
4.What is NIKI after-hours price?
5.Is NIKI stock trading now?
6.Where does NIKI sit relative to its 52-week high and low?
7.What sector is Niki BioSolutions, Inc. in?
8.What is Niki BioSolutions, Inc.'s market capitalization and where is it listed?
9.How is NIKI valued in terms of P/E ratio and EPS?
10.Does Niki BioSolutions, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
NIKI Stock Calculator
Estimate the value between NIKI shares and USD.
NIKI Shares to USD
1.00 NIKI shares = 2.019 USD
Calculations are estimates based on the latest available price and are for reference only.


